首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Low-molecular-weight heparin and intermittent pneumatic compression for thromboprophylaxis in critical patients
【2h】

Low-molecular-weight heparin and intermittent pneumatic compression for thromboprophylaxis in critical patients

机译:低分子量肝素和间歇性气压加压对危重患者的血栓预防

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The efficacy and safety of physiotherapeutic prophylaxis for venous thromboembolism in critically ill patients with heparin contraindication remains unclear. In the present study it was hypothesized that physiotherapy prophylaxis with intermittent pneumatic compression (IPC) would be safe and effective for patients unable to receive low-molecular-weight heparin (LMWH). In addition, this study investigated whether a combined therapy of IPC with LMWH would be more effective for the prophylaxis of deep vein thrombosis (DVT) in critical patients. A total of 500 patients were divided into four groups according to the prophylaxis of DVT. The IPC group consisted of 95 patients with heparin contraindication that received IPC treatment; the LMWH group consisted of 185 patients that received an LMWH injection; the LMWH + IPC group consisted of 75 patients that received IPC treatment and LMWH injection; and the control group consisted of 145 patients that received no IPC treatment or injection of LMWH. Each patient was evaluated clinically for development of DVT and the diagnosis was confirmed by Doppler study. Venous thromboembolism was a common complication among the trauma patients with severe injuries. Patients responded positively to the treatment used in the intervention groups. Patients exhibited an improved response to LMWH + ICP compared with IPC or LMWH alone, while no significant difference was detected between the IPC and LMWH groups. These results were applicable to patients that had a Wells score of ≥3; however, no significant differences in DVT incidence were observed among the patients who had a Wells score of <3. In this observational study, LMWH + ICP appeared to be more effective than either treatment alone in treating critically ill trauma patients with severe injuries that are at high risk for VTE and bleeding simultaneously.
机译:危重患者肝素禁忌症的静脉血栓栓塞治疗的物理疗法预防效果和安全性尚不清楚。在本研究中,假设对无法接受低分子量肝素(LMWH)的患者进行间歇性气动加压(IPC)物理疗法预防将是安全有效的。此外,本研究调查了IPC与LMWH的联合治疗对于预防重症患者的深静脉血栓形成(DVT)是否更有效。根据DVT的预防措施,将500例患者分为四组。 IPC组由95例接受IPC治疗的肝素禁忌症患者组成。 LMWH组由185例接受LMWH注射的患者组成。 LMWH + IPC组由75例接受IPC治疗和LMWH注射的患者组成。对照组包括145例未接受IPC治疗或未注射LMWH的患者。对每位患者进行DVT的临床评估,并通过多普勒研究确认诊断。静脉血栓栓塞是重伤患者中的常见并发症。患者对干预组中使用的治疗反应良好。与单独使用IPC或LMWH相比,患者对LMWH + ICP的反应有所改善,而IPC和LMWH组之间未发现明显差异。这些结果适用于韦尔斯得分≥3的患者;但是,在韦尔斯评分<3的患者中,DVT发生率没有显着差异。在这项观察性研究中,LMWH + ICP似乎比单独使用任何一种方法都更有效,可同时治疗严重受伤且重度VTE和出血风险的重症创伤患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号